Document is current
Any future updates will be listed below
-
Authors
Gale, Richard https://orcid.org/0009-0006-0213-6253
Awad, Mahmoud Husseiny https://orcid.org/0009-0001-9878-2447
Bailey, Clare
Cackett, Peter
Chhabra, Ramandeep
Downey, Louise
Ghanchi, Faruque https://orcid.org/0000-0002-4448-8162
Kotagiri, Ajay
Narendran, Nirodhini
Pearce, Ian
Peto, Tunde https://orcid.org/0000-0001-6265-0381
Sivaprasad, Sobha
Younis, Saad
Napier, Jackie
Gilbert, Rose
Ismat, Safeen
- License Information
-
More Information
Article History
Received: 15 May 2025
Revised: 27 November 2025
Accepted: 9 December 2025
First Online: 16 January 2026
Competing interests
: Richard Gale: Travel grants and honoraria from AbbVie, Amgen, Apellis, Astellas, Bayer, Biogen, Boehringer Ingelheim, Ocular Therapeutix and Roche. Mahmoud Husseiny Awad: Travel grants and honoraria from AbbVie, Bayer and Roche. Clare Bailey: Travel grants and honoraria from Alimera Sciences, Apellis, Bayer, Boehringer Ingelheim, Janssen Pharmaceuticals and Roche. Peter Cackett: Travel grants and honoraria from AbbVie, Apellis, Bayer, Novartis and Roche. Ramandeep Chhabra: Honoraria for advisory boards, travel grants and speaker engagements for educational meetings from Alimera Sciences, Bayer, Novartis and Roche. Louise Downey: Travel grants from Allergan, Bayer, Novartis and Roche; honoraria and research funding from AbbVie, Alimera Sciences, Allergan, Bausch + Lomb, Bayer, Biogen, Novartis and Roche. Faruque Ghanchi: Travel grants and honoraria from AbbVie, Alimera, Bayer, Boehringer Ingelheim, Heidelberg (UK) and Roche. Ajay Kotagiri: Advisory board attendances for AbbVie, Bayer, Novartis and Roche; speaker fees from AbbVie and Bayer; travel grants from AbbVie, Bayer, Novartis and Roche. Nirodhini Narendran: Travel grants and honoraria from Bayer, Novartis and Roche. Ian Pearce: Travel grants and honoraria from Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis and Roche. Tunde Peto: Speaker’s fee and honoraria from AbbVie, Apellis, Bayer, Boehringer Ingelheim, Heidelberg Engineering, Novartis, Optos and Roche; investigator-initiated grant (paid to institution) from Boehringer Ingelheim and Novartis. Eye editorial board member. Sobha Sivaprasad: Travel grants and honoraria from AbbVie, Adverum, Alimera Sciences, Amgen, Apellis, Astellas, Bayer, Biogen, Boehringer Ingelheim, Clearside Biomedical, Eyebiotech, EyePoint Pharmaceuticals, Janssen Pharmaceuticals, Kriya Therapeutics, Novo Nordisk, Ocular Therapeutix, OcuTerra, Optos, Ripple Therapeutics, Roche, Sanofi and Stealth BioTherapeutics. Eye editorial board member. Saad Younis: Travel grants and honoraria from AbbVie, Bayer and Roche. Jackie Napier was an employee of Bayer plc, UK, during the development of the manuscript, but is no longer affiliated with the company. Rose Gilbert and Safeen Ismat: Employees of Bayer plc, UK.
